SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+35.56%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$581M
AUM Growth
–
Cap. Flow
+$581M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
91.59%
Holding
53
New
51
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Ascendis Pharma
ASND
|
$162M |
| 2 |
NCNA
NuCana
NCNA
|
$88.3M |
| 3 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$64.1M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$41.5M |
| 5 |
Merus
MRUS
|
$36.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 94.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ascendis Pharma
ASND
$11.8B
| $162M | 27.87% | +2,479,514 | New | +$162M |
|
|
NCNA
2
NuCana
NCNA
$6.09M
| $88.3M | 15.17% | +4,666,666 | New | +$88.3M |
|
|
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $64.1M | 11.02% | +4,749,623 | New | +$64.1M |
|
|
BOLD
4
DELISTED
Audentes Therapeutics, Inc
BOLD
| $41.5M | 7.13% | +1,380,303 | New | +$41.5M |
|
|
5
Merus
MRUS
$4.98B
| $36.3M | 6.25% | +1,961,039 | New | +$36.3M |
|
|
ONCE
6
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $32M | 5.51% | +481,270 | New | +$32M |
|
7
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $32M | 5.49% | +2,893,221 | New | +$32M |
|
8
Natera
NTRA
$23.1B
| $28.7M | 4.94% | +3,100,560 | New | +$28.7M |
|
9
Aclaris Therapeutics
ACRS
$209M
| $27M | 4.64% | +1,539,480 | New | +$27M |
|
10
Apellis Pharmaceuticals
APLS
$3.48B
| $20.2M | 3.46% | +911,752 | New | +$20.2M |
|
|
AMRN
11
Amarin Corp
AMRN
$311M
| $10M | 1.72% | +3,321,588 | New | +$10M |
|
12
Ocugen
OCGN
$319M
| $5.71M | 0.98% | +2,077,040 | New | +$5.71M |
|
13
Synlogic
SYBX
$17M
| $5.39M | 0.93% | +574,972 | New | +$5.39M |
|
|
ATYR
14
aTyr Pharma
ATYR
$527M
| $4.95M | 0.85% | +1,866,126 | New | +$4.95M |
|
15
PDS Biotechnology
PDSB
$57.8M
| $3.37M | 0.58% | +2,852,711 | New | +$3.37M |
|
|
CHMA
16
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $2.45M | 0.42% | +1,630,221 | New | +$2.45M |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $1.58M | 0.27% | +9,379 | New | +$1.58M |
|
|
CYTO
18
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $1.25M | 0.22% | +781,818 | New | +$1.25M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.02M | 0.17% | +9,126 | New | +$1.02M |
|
20
Bristol-Myers Squibb
BMY
$96B
| $951K | 0.16% | +15,033 | New | +$951K |
|
21
Heron Therapeutics
HRTX
$207M
| $832K | 0.14% | +30,133 | New | +$832K |
|
|
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
| $794K | 0.14% | +186,774 | New | +$794K |
|
23
AstraZeneca
AZN
$248B
| $763K | 0.13% | +21,832 | New | +$763K |
|
24
PTC Therapeutics
PTCT
$3.92B
| $696K | 0.12% | +25,729 | New | +$696K |
|
|
AIMT
25
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $646K | 0.11% | +20,308 | New | +$646K |
|